Theranostic roles of machine learning in clinical management of kidney stone disease

Supatcha Sassanarakkit; Sudarat Hadpech; Visith Thongboonkerd

doi:10.1016/j.csbj.2022.12.004

Theranostic roles of machine learning in clinical management of kidney stone disease

Comput Struct Biotechnol J. 2022 Dec 5:21:260-266. doi: 10.1016/j.csbj.2022.12.004. eCollection 2023.

Authors

Supatcha Sassanarakkit¹, Sudarat Hadpech¹, Visith Thongboonkerd¹

Affiliation

¹ Medical Proteomics Unit, Office for Research and Development, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok 10700, Thailand.

Abstract

Kidney stone disease (KSD) is a common illness caused by deposition of solid minerals formed inside the kidney. The disease prevalence varies, based on sociodemographic, lifestyle, dietary, genetic, gender, age, environmental and climatic factors, but has been continuously increasing worldwide. KSD is a highly recurrent disease, and the recurrence rate is about 11% within two years after the stone removal. Recently, machine learning has been widely used for KSD detection, stone type prediction, determination of appropriate treatment modality and prediction of therapeutic outcome. This review provides a brief overview of KSD and discusses how machine learning can be applied to diagnostics, therapeutics and prognostics in clinical management of KSD for better therapeutic outcome.

Keywords: Artificial intelligence; Deep learning; Diagnostics; Outcome; Prognostics; Recurrence; Therapeutics.

Publication types

Review